PDCD4 and prostate carcinoma: Zhu et al35 showed that rs55829688 CC + rs145204276 del/del genotype had an impact on the prognosis and survival rate of prostate cancer patients through the regulation of miR‐21/miR‐1284 expression, which consequently affected PDCD4, PTEN and AKT expression.